Kim M Unertl1, Habiba Jaffa2, Julie R Field3, Lisa Price3, Josh F Peterson4. 1. Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN. 2. The University of Manchester, Manchester, UK, M13 9PL. 3. Institute of Clinical and Translational Research, Vanderbilt University School of Medicine, Nashville, TN. 4. Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN ; Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN.
Abstract
AIM: To describe the knowledge and attitudes of clinicians participating in a large pharmacogenomics implementation program. MATERIALS & METHODS: Semi-structured interviews with 15 physicians and nurse practitioners were conducted. RESULTS: Three categories of themes were identified: preparation and knowledge, pharmacogenomics usage in practice, and future management of genomic variants. Providers expressed an inability to keep up with the rapid pace of evidence generation and indicated strong support for clinical decision support to assist with genotype-tailored therapies. Concerns raised by clinicians included effectively communicating results, long-term responsibility for actionable results and hand-offs with providers outside the implementation program. CONCLUSIONS: Clinicians identified their own knowledge deficits, workflow integration, and longitudinal responsibility as challenges to successful usage of pharmacogenomics in clinical practice.
AIM: To describe the knowledge and attitudes of clinicians participating in a large pharmacogenomics implementation program. MATERIALS & METHODS: Semi-structured interviews with 15 physicians and nurse practitioners were conducted. RESULTS: Three categories of themes were identified: preparation and knowledge, pharmacogenomics usage in practice, and future management of genomic variants. Providers expressed an inability to keep up with the rapid pace of evidence generation and indicated strong support for clinical decision support to assist with genotype-tailored therapies. Concerns raised by clinicians included effectively communicating results, long-term responsibility for actionable results and hand-offs with providers outside the implementation program. CONCLUSIONS: Clinicians identified their own knowledge deficits, workflow integration, and longitudinal responsibility as challenges to successful usage of pharmacogenomics in clinical practice.
Entities:
Keywords:
attitudes; personalized medicine; pharmacogenomics; qualitative research; translational research
Authors: E J Stanek; C L Sanders; K A Johansen Taber; M Khalid; A Patel; R R Verbrugge; B C Agatep; R E Aubert; R S Epstein; F W Frueh Journal: Clin Pharmacol Ther Date: 2012-01-25 Impact factor: 6.875
Authors: Jason L Vassy; Kurt D Christensen; Melody J Slashinski; Denise M Lautenbach; Sridharan Raghavan; Jill Oliver Robinson; Jennifer Blumenthal-Barby; Lindsay Zausmer Feuerman; Lisa Soleymani Lehmann; Michael F Murray; Robert C Green; Amy L McGuire Journal: Per Med Date: 2015 Impact factor: 2.512
Authors: J K Hicks; K R Crews; J M Hoffman; N M Kornegay; M R Wilkinson; R Lorier; A Stoddard; W Yang; C Smith; C A Fernandez; S J Cross; C Haidar; D K Baker; S C Howard; W E Evans; U Broeckel; M V Relling Journal: Clin Pharmacol Ther Date: 2012-09-19 Impact factor: 6.875
Authors: S A Scott; K Sangkuhl; C M Stein; J-S Hulot; J L Mega; D M Roden; T E Klein; M S Sabatine; J A Johnson; A R Shuldiner Journal: Clin Pharmacol Ther Date: 2013-05-22 Impact factor: 6.875
Authors: J M Pulley; J C Denny; J F Peterson; G R Bernard; C L Vnencak-Jones; A H Ramirez; J T Delaney; E Bowton; K Brothers; K Johnson; D C Crawford; J Schildcrout; D R Masys; H H Dilks; R A Wilke; E W Clayton; E Shultz; M Laposata; J McPherson; J N Jirjis; D M Roden Journal: Clin Pharmacol Ther Date: 2012-05-16 Impact factor: 6.875
Authors: Josh F Peterson; Erica Bowton; Julie R Field; Marc Beller; Jennifer Mitchell; Jonathan Schildcrout; William Gregg; Kevin Johnson; Jim N Jirjis; Dan M Roden; Jill M Pulley; Josh C Denny Journal: Genet Med Date: 2013-09-05 Impact factor: 8.822
Authors: Carol R Horowitz; Lori A Orlando; Anne M Slavotinek; Josh Peterson; Frank Angelo; Barbara Biesecker; Vence L Bonham; Linda D Cameron; Stephanie M Fullerton; Bruce D Gelb; Katrina A B Goddard; Benyam Hailu; Ragan Hart; Lucia A Hindorff; Gail P Jarvik; Dave Kaufman; Eimear E Kenny; Sara J Knight; Barbara A Koenig; Bruce R Korf; Ebony Madden; Amy L McGuire; Jeffrey Ou; Melissa P Wasserstein; Mimsie Robinson; Howard Leventhal; Saskia C Sanderson Journal: Am J Hum Genet Date: 2019-05-16 Impact factor: 11.025
Authors: Carolyn R Rohrer Vitek; Noura S Abul-Husn; John J Connolly; Andrea L Hartzler; Terrie Kitchner; Josh F Peterson; Luke V Rasmussen; Maureen E Smith; Sarah Stallings; Marc S Williams; Wendy A Wolf; Cynthia A Prows Journal: Pharmacogenomics Date: 2017-06-22 Impact factor: 2.533
Authors: R P McKillip; B A Borden; P Galecki; S A Ham; L Patrick-Miller; J P Hall; S Hussain; K Danahey; M Siegler; M J Sorrentino; Y Sacro; A M Davis; D T Rubin; K Lipstreuer; T S Polonsky; R Nanda; W R Harper; J L Koyner; D L Burnet; W M Stadler; M J Ratain; D O Meltzer; P H O'Donnell Journal: Clin Pharmacol Ther Date: 2017-04-04 Impact factor: 6.875
Authors: Jennifer L St Sauver; Suzette J Bielinski; Janet E Olson; Elizabeth J Bell; Michaela E Mc Gree; Debra J Jacobson; Jennifer B McCormick; Pedro J Caraballo; Paul Y Takahashi; Veronique L Roger; Carolyn R Rohrer Vitek Journal: Am J Med Date: 2016-05-05 Impact factor: 4.965
Authors: J F Peterson; J R Field; K M Unertl; J S Schildcrout; D C Johnson; Y Shi; I Danciu; J H Cleator; J M Pulley; J A McPherson; J C Denny; M Laposata; D M Roden; K B Johnson Journal: Clin Pharmacol Ther Date: 2016-02-17 Impact factor: 6.875
Authors: Nicholas J Keeling; Tyler J Dunn; John P Bentley; Sujith Ramachandran; James M Hoffman; Meagen Rosenthal Journal: Genet Med Date: 2021-04-29 Impact factor: 8.822
Authors: Agnes Sebastian; June C Carroll; Leslie E Oldfield; Chloe Mighton; Salma Shickh; Elizabeth Uleryk; Yvonne Bombard Journal: Genet Med Date: 2021-01-08 Impact factor: 8.822